SK285603B6 - Vektor na výrobu IL-4 a muteínov IL-4 v kmeni Escherichia coli, vektor obsahujúci DNA sekvenciu, Escherichia coli transformovaná jedným alebo viacerými vektormi a použitie vektora - Google Patents

Vektor na výrobu IL-4 a muteínov IL-4 v kmeni Escherichia coli, vektor obsahujúci DNA sekvenciu, Escherichia coli transformovaná jedným alebo viacerými vektormi a použitie vektora Download PDF

Info

Publication number
SK285603B6
SK285603B6 SK76-2000A SK762000A SK285603B6 SK 285603 B6 SK285603 B6 SK 285603B6 SK 762000 A SK762000 A SK 762000A SK 285603 B6 SK285603 B6 SK 285603B6
Authority
SK
Slovakia
Prior art keywords
vector
escherichia coli
muteins
gene
expression
Prior art date
Application number
SK76-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK762000A3 (en
Inventor
Heiner Apeler
Hermann Wehlmann
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of SK762000A3 publication Critical patent/SK762000A3/sk
Publication of SK285603B6 publication Critical patent/SK285603B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5406IL-4
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/72Expression systems using regulatory sequences derived from the lac-operon

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK76-2000A 1999-01-20 2000-01-19 Vektor na výrobu IL-4 a muteínov IL-4 v kmeni Escherichia coli, vektor obsahujúci DNA sekvenciu, Escherichia coli transformovaná jedným alebo viacerými vektormi a použitie vektora SK285603B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99100967A EP1022339B1 (de) 1999-01-20 1999-01-20 Plasmide, deren Konstruktion und Anwendung zur Herstellung von Interleukin-4 und dessen Muteine

Publications (2)

Publication Number Publication Date
SK762000A3 SK762000A3 (en) 2000-08-14
SK285603B6 true SK285603B6 (sk) 2007-04-05

Family

ID=8237378

Family Applications (1)

Application Number Title Priority Date Filing Date
SK76-2000A SK285603B6 (sk) 1999-01-20 2000-01-19 Vektor na výrobu IL-4 a muteínov IL-4 v kmeni Escherichia coli, vektor obsahujúci DNA sekvenciu, Escherichia coli transformovaná jedným alebo viacerými vektormi a použitie vektora

Country Status (15)

Country Link
US (1) US6506590B1 (de)
EP (1) EP1022339B1 (de)
JP (2) JP2000210091A (de)
KR (1) KR100665148B1 (de)
AT (1) ATE334202T1 (de)
AU (1) AU772897B2 (de)
CA (1) CA2294575C (de)
CZ (1) CZ294279B6 (de)
DE (1) DE69929638T2 (de)
DK (1) DK1022337T3 (de)
ES (1) ES2269027T3 (de)
HU (1) HU224491B1 (de)
NO (1) NO327317B1 (de)
PT (1) PT1022337E (de)
SK (1) SK285603B6 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10022258A1 (de) 2000-05-08 2001-11-15 Bayer Ag Reinigung von Proteineinschlusskörpern durch Querstrom-Mikrofiltration
KR100443570B1 (ko) * 2001-07-31 2004-08-09 크레아젠 주식회사 재조합 인간 인터루킨-4의 제조방법
EP1314739A1 (de) 2001-11-22 2003-05-28 Bayer Ag Verfahren zur Renaturierung rekombinanter, Disulfid-enthaltender Proteine bei hohen Proteinkonzentrationen in Gegenwart von Aminen
JP2006055082A (ja) * 2004-08-20 2006-03-02 National Institute Of Advanced Industrial & Technology 発光甲虫由来赤色発光酵素安定体の生産及び精製法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689406A (en) * 1983-08-10 1987-08-25 Amgen Enhancement of microbial expression of polypeptides
AU597951B2 (en) * 1986-03-27 1990-06-14 Monsanto Company Enhanced protein production in bacteria by employing a novel ribosome binding site
ATE123526T1 (de) * 1987-08-17 1995-06-15 Hoffmann La Roche Hochreprimierbare expressionskontrollsequenzen.
FR2724665B1 (fr) * 1994-09-16 1996-12-20 Rhone Poulenc Rorer Sa Procede de production de proteines recombinantes, plasmides et cellules modifiees
MY124565A (en) * 1996-07-19 2006-06-30 Bayer Corp High-affinity interleukin-4-muteins

Also Published As

Publication number Publication date
HU224491B1 (hu) 2005-09-28
DK1022337T3 (da) 2006-11-06
AU772897B2 (en) 2004-05-13
ATE334202T1 (de) 2006-08-15
DE69929638T2 (de) 2006-09-21
CA2294575C (en) 2009-04-07
SK762000A3 (en) 2000-08-14
HU0000185D0 (en) 2000-04-28
EP1022339B1 (de) 2006-02-01
PT1022337E (pt) 2006-11-30
HUP0000185A2 (en) 2002-09-28
KR20000053523A (ko) 2000-08-25
NO20000262D0 (no) 2000-01-19
KR100665148B1 (ko) 2007-01-09
DE69929638D1 (de) 2006-04-13
CZ2000214A3 (cs) 2000-08-16
NO327317B1 (no) 2009-06-08
JP2000210091A (ja) 2000-08-02
CA2294575A1 (en) 2000-07-20
CZ294279B6 (cs) 2004-11-10
EP1022339A1 (de) 2000-07-26
ES2269027T3 (es) 2007-04-01
US6506590B1 (en) 2003-01-14
AU1250700A (en) 2000-07-27
NO20000262L (no) 2000-07-21
JP2010284174A (ja) 2010-12-24

Similar Documents

Publication Publication Date Title
US6291245B1 (en) Host-vector system
CA1316850C (en) Gram-positive expression control sequences
EP0972838B1 (de) Escherichia coli Wirt/Vektorsystem basierend auf einer antibiotikafreien Selektion durch Komplementation einer Auxotrophie
Paddon et al. Expression of Bacillus amyloliquefaciens extracellular ribonuclease (barnase) in Escherichia coli following an inactivating mutation
Altenbuchner et al. Tn1721-encoded tetracycline resistance: mapping of structural and regulatory genes mediating resistance
JPH10507368A (ja) ヘテロローガスなポリペプチドを分泌させるための方法および組成物
JP2010284174A (ja) プラスミド、それらの構築およびそれらのインターロイキン−4およびインターロイキン−4ムテインの製造における使用
MXPA04005717A (es) Sistema de expresion.
KR100358948B1 (ko) 인체 과립성 백혈구의 콜로니 자극인자를 분비하는 대장균
EP1022337B1 (de) Plasmide, deren Konstruktion und deren Verwendung zur Herstellung von Interleukin-4 und Interleukin-4 Muteine
US5654169A (en) Vectors and transformed host cells for recombinant protein production at reduced temperatures
EP0121569B1 (de) Neuer vektor
EP0105554A1 (de) DNS und Plasmide
CN113528415A (zh) 一种nampt酶生产菌及其应用
Kenri et al. Construction and characterization of an Escherichia coli mutant deficient in the metY gene encoding tRNAf2Met: either tRNAf1Met or tRNAf2Met is required for cell growth
EP2109671B1 (de) Expressionskassette, verwendung der expressionskassette, vektor, wirtszelle, verfahren zur herstellung eines polypeptids
Bendiak et al. Fine-structure mapping of the rts, rplK, rplL, and rpoB genes of Escherichia coli
Roytrakul et al. A Rapid and Simple Method for Construction and Expression of a Synthetic
Bryant Phycobilisomes of Synechococcus sp. PCC 7002, Pseudanabaena sp. PCC 7409, and Cyanophora paradoxa: an analysis by molecular genetics
CN100379870C (zh) 冷诱导的表达载体
Beck et al. The tetracycline-resistance transposon Tn10 inhibits translocation of Tn10
EP1461437B1 (de) Expressionsvektoren und promotoren für heterologe genexpression
Takebe et al. In vitro construction of the tufB-lacZ fusion: analysis of the regulatory mechanism of tufB promoter
EP0217327A2 (de) Für eine Variante des Elongationsfaktors 2 kodierende DNS-Sequenz
KR20190026426A (ko) 코돈 최적화된 il-21 및 이의 용도